SPGI vs MA vs CME Stock Comparison

S&P Global, Mastercard and Cme Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (TW) Create a free account to keep reading and compare up to 10 companies.
SPGI S&P Global Inc.
$460.50 +17.3% 1M -2.7% 1Y
Market cap
$133.50B
P/E
26.9x
Revenue (TTM)
$17.21B
Div. yield
0.84%
Financial Data and Analytics Financial Services
4 wins
MA Mastercard Inc
$635.70 +12.8% 1M +14.6% 1Y
Market cap
$553.50B
P/E
30.6x
Revenue (TTM)
$36.29B
Div. yield
0.55%
Payment Networks Financial Services
4 wins
CME Cme Group Inc.
$296.42 +12.6% 1M +13.3% 1Y
Market cap
$105.95B
P/E
24.0x
Revenue (TTM)
$6.97B
Div. yield
3.37%
Exchanges Financial Services
4 wins

Head to Head

12 decided of 12

Mastercard leads on 4 of the 12 questions below (Mastercard 4, Cme 4, S&P Global 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSPGIMACMELeader
Larger companyMarket capitalisation $133.50B $553.50B $105.95B MA
Cheaper on earningsLower P/E, profitable companies only 26.9x 30.6x 24.0x CME
Cheaper on forward earningsLower price / next fiscal year consensus EPS 24.4x 30.3x 25.2x SPGI
Faster revenue growthRevenue growth, trailing twelve months +18.2% +15.3% +9.0% SPGI
More profitableNet margin, trailing twelve months 29.0% — 63.3% CME
Better return on capitalReturn on invested capital 14.9% — 11.7% SPGI
Less leveragedLower net debt / EBITDA 1.2x — 0.2x CME
Higher dividend yieldTrailing dividend yield 0.84% 0.55% 3.37% CME
Better 1-year returnPrice return, last 12 months -2.7% +14.6% +13.3% MA
Better 5-year returnAnnualised price return, 5 years -0.6%/yr +13.6%/yr +6.1%/yr MA
Less volatileAnnualised volatility, 1 year 30.6% 22.9% 25.3% MA
Higher overall scoreMean of the five percentile scores vs peers 62/100 44/100 61/100 SPGI

Percentile Scorecard

SPGIMACME

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSPGIMACME
Valuation 26 #700 of 941 9 #857 of 941 43 #55 of 96
Growth 76 #148 of 615 66 #213 of 615 22 #51 of 65
Profitability 93 #45 of 586 95 #29 of 586 89 #8 of 65
Financial Health 65 #233 of 667 43 #380 of 667 59 #39 of 93
Shareholder Returns 52 #336 of 704 6 #660 of 704 92 #4 of 40
Overall 62 44 61
  • SPGI ranked among 1,003 companies in Financial Services
  • MA ranked among 1,003 companies in Financial Services
  • CME ranked among 110 companies in Capital Markets

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSPGIMACMESPY
1 month +17.3%+12.8%+12.6% +0.7%
3 months +11.0%+10.1%+10.9% +3.7%
6 months +6.8%+26.4%+3.0% +7.1%
Year to date -11.9%+11.4%+8.5% +12.8%
1 year -2.7%+14.6%+13.3% +11.9%
3 years +33.5%+70.7%+40.3% +85.2%
3 years, per year +10.1%+19.5%+11.9% +22.8%
5 years -2.9%+89.5%+34.4% +67.6%
5 years, per year -0.6%+13.6%+6.1% +10.9%
10 years +276.6%+494.7%+196.7% +262.0%
10 years, per year +14.2%+19.5%+11.5% +13.7%

Risk

MeasureSPGIMACMESPY
Volatility, 1Y 30.6%22.9%25.3% 12.7%
Downside volatility, 1Y 35.1%22.5%27.7% 12.6%
Beta vs S&P 500, 1Y 0.320.25-0.38 1.00
Return / volatility, 1Y -0.090.640.53 0.94
Max drawdown, 5Y -40.2%-28.6%-33.1% -25.4%
From 52-week high -15.7%0.0%-9.2% -1.2%
52-week high $546.35$635.70$326.46 $779.14
52-week low $386.35$471.55$218.58 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSPGIMACME
P/E now vs peer median 26.9xmedian 13.0x 30.6xmedian 13.0x 24.0xmedian 29.6x
P/S now vs peer median 7.8xmedian 3.2x 15.3xmedian 3.2x 15.2xmedian 3.1x
EV/EBITDA now vs peer median 15.8xmedian 7.7x —median 7.7x 22.0xmedian 13.0x
P/FCF now vs peer median 22.9xmedian 10.7x 29.4xmedian 10.7x 24.5xmedian 16.5x
P/B now vs peer median 6.7xmedian 1.2x 82.1xmedian 1.2x 4.0xmedian 2.3x
PEG now vs peer median 0.90median 0.90 —median 0.90 1.75median 0.48

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSPGIMACME
Revenue $17.21B $36.29B $6.97B
Gross profit $12.21B – –
Operating income $7.77B $21.27B $4.58B
Net income $5.40B $16.96B $4.42B
Free cash flow $5.84B – $4.33B
EPS (diluted) $17.10 – $12.31
Cash & equivalents $2.44B $10.15B $2.20B
Total debt $13.06B – $13.69B
Shares (diluted) 291.60M 883.00M 358.64M
Enterprise value $128.70B $553.49B $94.29B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSPGIMACME
P/E 26.9x 30.6x 24.0x
P/FCF 22.9x 29.4x 24.5x
P/Operating cash flow 22.3x 32.8x 23.9x
P/S 7.8x 15.3x 15.2x
P/B 6.7x 82.1x 4.0x
P/Tangible book 16.9x 534.3x 4.4x
EV/EBITDA 15.8x – 22.0x
EV/EBIT 18.5x – 23.4x
EV/Revenue 8.4x 15.3x 15.4x
EV/FCF 24.7x – 24.7x
EV/Operating cash flow 24.0x 32.8x 24.2x
PEG (3Y EPS CAGR) 0.90 – 1.75

Growth

14 metrics
MetricSPGIMACME
Revenue growth (1Y) 18.2% 15.3% 9.0%
Revenue CAGR (3Y) 11.9% 14.2% 9.2%
Gross profit growth (1Y) 19.7% – –
Gross profit CAGR (3Y) 14.4% – –
Operating income growth (1Y) 29.7% 18.6% 10.1%
Operating income CAGR (3Y) 26.4% 15.4% 12.2%
Net income growth (1Y) 18.3% 19.0% 17.3%
Net income CAGR (3Y) 25.3% 15.8% 13.1%
EPS growth (1Y) 23.4% – 19.4%
EPS CAGR (3Y) 29.9% – 13.7%
Operating cash flow growth (1Y) 18.5% -3.5% 6.4%
Operating cash flow CAGR (3Y) 19.8% 15.5% 9.3%
Free cash flow growth (1Y) 19.4% – 6.1%
Free cash flow CAGR (3Y) 20.2% – 9.4%

Profitability

14 metrics
MetricSPGIMACME
Gross margin 70.9% – –
EBITDA margin 53.1% – 69.8%
Operating margin 45.1% – 65.7%
Pretax margin 43.4% – 82.8%
Net margin 29.0% – 63.3%
FCF margin 33.9% – 62.1%
Operating cash flow margin 34.8% 46.5% 63.5%
Return on equity 21.0% 274.6% 16.6%
Return on assets 9.7% 29.3% 2.3%
Return on invested capital 14.9% – 11.7%
Return on capital employed 16.6% – 12.3%
Asset turnover 0.3x 0.6x 0.0x
Cash conversion (OCF / net income) 1.1x 1.0x 1.0x
Stock comp / revenue 1.2% 1.8% 1.4%

Financial Health

11 metrics
MetricSPGIMACME
Debt / assets 27.2% – 1.8%
Debt / equity 0.7x – 0.1x
Net debt / EBITDA 1.2x – 0.2x
Debt / FCF 2.2x – 0.8x
Liabilities / assets 58.7% 88.4% 86.2%
Equity / assets 41.3% 11.6% 13.8%
Interest coverage 24.0x – 26.2x
Current ratio 0.7x 1.0x 1.0x
Quick ratio 0.6x – 0.0x
Cash ratio 0.3x – 0.0x
Altman Z-score 4.16 – 0.56

Shareholder Returns

7 metrics
MetricSPGIMACME
Dividend yield 0.8% 0.5% 3.4%
Net buyback yield 4.9% – –
Shareholder yield 5.8% 0.5% 3.4%
Payout ratio (earnings) 21.2% – –
Payout ratio (FCF) 19.6% – –
Dividend growth (1Y) -1.2% – –
Dividend CAGR (3Y) 0.2% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSPGIMACME
Forward P/E 24.4xFY2026 30.3xFY2026 25.2xFY2026
EPS, next fiscal year $18.86FY2026 $20.99FY2026 $11.74FY2026
EPS growth, next FY +11.9%FY2026 +23.4%FY2026 +4.8%FY2026
EPS growth, the year after +12.9% +14.7% +19.0%
Revenue, next fiscal year $15.46BFY2026 $38.99BFY2026 $7.27BFY2026
Revenue growth, next FY +0.8%FY2026 +18.9%FY2026 +11.6%FY2026
Revenue growth, the year after +6.6% +0.4% +7.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSPGIMACME
Held by institutions 87.5% 87.5% 88.9%
Institutions holding 2,003 3,585 1,692
Change in shares held, QoQ +1.6% +0.6% +0.4%
Institutions buying 873 1,590 822
Institutions selling 876 1,527 656
Buyers to sellers 1.00 1.04 1.25

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SPGIMACME
SPGI 1.00 0.43 0.21
MA 0.43 1.00 0.18
CME 0.21 0.18 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SPGI, MA and CME?

Mastercard (MA) is the largest by market capitalisation: S&P Global (SPGI) $133.50B, Mastercard (MA) $553.50B, Cme (CME) $105.95B.

Which stock is cheaper, SPGI, MA and CME?

Cme (CME) trades on the lowest price-to-earnings ratio (S&P Global (SPGI) 26.9x, Mastercard (MA) 30.6x, Cme (CME) 24.0x). On next year's consensus earnings, S&P Global (SPGI) is cheapest (S&P Global (SPGI) 24.4x, Mastercard (MA) 30.3x, Cme (CME) 25.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

S&P Global (SPGI) grew revenue fastest over the trailing twelve months: S&P Global (SPGI) +18.2%, Mastercard (MA) +15.3%, Cme (CME) +9.0%.

Which company is more profitable?

Cme (CME) has the highest net margin (S&P Global (SPGI) 29.0%, Cme (CME) 63.3%). On return on invested capital, S&P Global (SPGI) leads (S&P Global (SPGI) 14.9%, Cme (CME) 11.7%).

Which stock has performed better?

Over the past year Mastercard (MA) returned the most: S&P Global (SPGI) -2.7%, Mastercard (MA) +14.6%, Cme (CME) +13.3%. Over five years, Mastercard (MA) compounded fastest (S&P Global (SPGI) -0.6%/yr, Mastercard (MA) +13.6%/yr, Cme (CME) +6.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Cme (CME) has the highest dividend yield: S&P Global (SPGI) 0.84%, Mastercard (MA) 0.55%, Cme (CME) 3.37%.

Which stock is riskier?

By one-year price volatility, Mastercard (MA) has been the steadiest (S&P Global (SPGI) 30.6%, Mastercard (MA) 22.9%, Cme (CME) 25.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SPGI, MA and CME?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mastercard (MA) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.